Multiple Sclerosis (MS) is one of the most researched neurological conditions in the world – yet for decades, the focus has been on slowing the immune attack rather than repairing the damage it causes. Most standard treatments reduce inflammation, but they do not rebuild myelin, restore nerve function, or reverse disability.
Today, this is changing.
Thanks to breakthroughs in regenerative medicine and non-invasive neuromodulation, researchers are discovering ways to:
Two major innovations are leading the way:
MS damages the brain and spinal cord through inflammation and loss of myelin — the insulation around nerve fibers.
Without myelin, nerve signals become slow or blocked, leading to symptoms such as:
STEM Cells bring new tools to the fight:
The goal is no longer just to suppress MS –
but to support actual recovery.
MSC Therapy: Improvements in Function, Inflammation & MRI Markers
Uccelli, Karussis, Atkins & others (Phase I/II Studies)
Across several trials involving MSC injections (intravenous or intrathecal):
A 2021 meta-analysis showed MSC therapy is consistently safe and associated with functional improvement in progressive MS.
HSCT: One of the Most Effective Treatments for Progressive MS
Burt et al., JAMA 2019 — Landmark Randomized Trial
This trial compared standard MS drugs vs. HSCT.
Results were dramatic:
For some patients, HSCT represents the closest thing to a “reset button” for the immune system.
Remyelination Trials
Li et al., 2020–2024
Early-phase studies show that stem cells may:
This line of research is expanding quickly.
While STEM Cells improve the biological environment, neurostimulation enhances the functional environment, helping the brain connect and adapt.
Three types are especially promising:
tDCS uses mild, painless electrical currents to improve brain function.
Benefits shown in MS trials:
tDCS also increases neuroplasticity, making physiotherapy more effective.
TPS uses focused acoustic pulses to stimulate deep brain networks. It is already approved in Europe for Alzheimer’s disease and is being explored in MS.
Potential benefits in MS:
TPS is painless, fast, and highly targeted.
The vagus nerve links the body to the brain’s inflammatory and learning systems.
Studies show VNS can:
Non-invasive taVNS (trans-auricular) is especially appealing for MS patients due to its safety and simplicity.
Together, they aim not only to stop MS –
but to improve function and quality of life.
For the first time in MS history, we are seeing treatments aimed at:
This represents a profound shift from “slowing decline” to creating the possibility of recovery.
The brain can heal. The nervous system can repair.
And with the right tools, your future may contain more strength, clarity, and independence than you ever imagined.
These changes often accumulate gradually over weeks to months.
Patients undergoing regenerative and neuromodulatory therapies frequently describe:
STEM Cell Vienna delivers cutting-edge regenerative treatments with a guaranteed standard of excellence. We provide priority access to accredited clinics, tailored treatment plans, and financial support programs.
Discover the unique advantages of STEM Cell Treatment for your long-term health. Take a moment to complete the form with care, ensuring every required field is filled in so we can offer the most accurate guidance.
The medical and administrative teams expressly dissociate themselves from any form of advertising or promotional activity in relation to the Pro Bono Program, whether the support provided is partial or full.
Respect for patient dignity, privacy, and confidentiality remains a fundamental priority. Accordingly, no personal data, identifying information, or photographs of patients or of the parents of children with medical conditions will be published.
Any video or graphic materials displayed on this platform include only patients or families who:
Have not benefited from the Pro Bono Program;
Have benefited partially or fully from the Program, in collaboration with associations, sponsors, or through direct support provided by STEM Cell Vienna
This clarification is provided in the interest of transparency and to ensure a clear understanding of the context in which such materials were produced and published.